- NEOM Investment Fund invested in Liberation Labs to support Topian in building a precision-fermentation food facility in Saudi Arabia.
- The partnership boosts Saudi Arabia’s food security and positions it as a global leader in novel-food biomanufacturing technologies.
- This move aims to strengthen NEOM’s role as an ecosystem builder and investor in the region’s growing knowledge-based economy.
NEOM
What happened? NEOM Investment Fund (NIF), the investment arm of NEOM, announced an investment in Liberation Labs.
What is the purpose? This partnership aims to set the foundation for Liberation Labs to support Topian, NEOM’s food company. This is to aid it in designing and developing an advanced precision-fermentation facility in the Kingdom.
This also lays the foundation for scalable solutions for Topian’s business while advancing the Kingdom’s position as an advanced food biomanufacturer.
Additionally, the investment aims to strengthen NEOM’s role as an investor and ecosystem developer.
Dr. Juan Carlos Motamayor, CEO of Topian, said, “ This investment will not only help reduce food imports and improve food security but will also create new economic opportunities and high-skilled jobs, giving the Kingdom a competitive advantage in the dynamic, high-value novel-food sector.”
Biotechnology
Who are they? NEOM is a region in northwest Saudi Arabia on the Red Sea being built as a place where entrepreneurship will be the driving force for the future. Moreover, it aims to serve as a hub for innovation and entrepreneurs to research, incubate and commercialize new technologies and enterprises.
NEOM Investment Fund (NIF) is the investment arm of NEOM, accelerating the growth of its 15 knowledge-economy sectors. Furthermore, NIF prioritizes investments that will aid in transforming NEOM’s goals into reality.
Liberation Labs is a precision-fermentation biomanufacturer with a global network of purpose-built manufacturing facilities. It seeks to enable the next wave of biotechnology advancements to produce bio-based consumer products at scale.
If you see something out of place or would like to contribute to this story, check out our Ethics and Policy section.
